China’s NMPA Approves Sarclisa for Newly Diagnosed Multiple Myeloma Patients Ineligible for Stem Cell Transplant

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomid...

February 03, 2025 | Monday | News
Vertex Pharmaceuticals Announces FDA Approval of JOURNAVX™ (Suzetrigine) for Acute Pain Treatment

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzet...

January 31, 2025 | Friday | News
SeaBeLife Introduces SBL03: A First-of-Its-Kind Topical Treatment for Retinal Cell Necrosis in Geographic Atrophy

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect retina fr...

January 30, 2025 | Thursday | News
AstraZeneca and Daiichi Sankyo's Enhertu Gains FDA Approval for HER2-Low and HER2-Ultralow Metastatic Breast Cancer

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unre...

January 28, 2025 | Tuesday | News
Abyssinia Biosciences and Cordance Medical Partner to Explore Focused Ultrasound for Alzheimer's Diagnosis and Treatment

Abyssinia Biosciences and Cordance Medical announced  that they have entered into a collaborative agreement to explore focused ultrasound in diagnosti...

January 24, 2025 | Friday | News
EU Approves Sarclisa in Combination with VRd for Newly Diagnosed Multiple Myeloma Patients Ineligible for Stem Cell Transplant

Following the adoption of a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...

January 23, 2025 | Thursday | News
Roche Receives FDA 510(k) Clearance and CLIA Waiver for Cobas® Liat STI Multiplex Assay Panels

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvem...

January 23, 2025 | Thursday | News
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
Fermion and Simcere Partner to Advance Innovative SSTR4 Agonist for Pain Management in Greater China

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain ...

January 20, 2025 | Monday | News
Eurofins Viracor Launches Groundbreaking Quantitative PCR Assay for Chagas Disease Detection

 Eurofins Viracor, LLC a leading provider of specialty diagnostic testing, and part of the global network of Eurofins companies, is pleased to announc...

January 17, 2025 | Friday | News
Silexion Therapeutics Prices Public Offering to Raise $5 Million for RNAi Cancer Therapy Development

Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA inter...

January 16, 2025 | Thursday | News
Advanced Genomics APAC Partners with Cancer Precision Medicine to Launch GALEAS™ Bladder Cancer Screening Test in Japan

Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) is pl...

January 15, 2025 | Wednesday | News
Bio-Rad Launches Nuvia wPrime 2A Media for Scalable Biomolecule Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of ...

January 15, 2025 | Wednesday | News
Grifols Receives $21 Million Grant from The Michael J. Fox Foundation to Advance Early Detection of Parkinson's Disease

Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, announced it has received a...

January 15, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close